| Armada Hoffler Properties (NYSE:AHH) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $11.00 price target on the stock. This represents a 10.1% upside from the current price of $9.99. |
| Albemarle (NYSE:ALB) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $96.00 price target on the stock. This represents a 11.1% upside from the current price of $86.38. |
| Applied Digital (NASDAQ:APLD) is now covered by analysts at Compass Point. They set a "buy" rating and a $10.00 price target on the stock. This represents a 47.3% upside from the current price of $6.79. |
| Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $41.00 price target on the stock. This represents a 150.7% upside from the current price of $16.35. |
| Chemours (NYSE:CC) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $27.00 price target on the stock. This represents a 40.6% upside from the current price of $19.21. |
| Cardiol Therapeutics (NASDAQ:CRDL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock. This represents a 444.7% upside from the current price of $1.29. |
| Eledon Pharmaceuticals (NASDAQ:ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock. This represents a 98.9% upside from the current price of $4.52. |
| Emerson Electric (NYSE:EMR) is now covered by analysts at Daiwa Capital Markets. They set an "outperform" rating and a $147.00 price target on the stock. This represents a 15.4% upside from the current price of $127.42. |
| Element Solutions (NYSE:ESI) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $28.00 price target on the stock. This represents a 10.2% upside from the current price of $25.41. |
| Chesapeake Energy (NASDAQ:EXE) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $96.00 price target on the stock. This represents a 5.1% downside from the current price of $101.17. |
| Indivior (NASDAQ:INDV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock. This represents a 31.1% upside from the current price of $12.20. |
| INmune Bio (NASDAQ:INMB) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $23.00 price target on the stock. This represents a 189.9% upside from the current price of $7.94. |
| Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 227.2% upside from the current price of $7.03. |
| Minerals Technologies (NYSE:MTX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $103.00 price target on the stock. This represents a 32.9% upside from the current price of $77.47. |
| Oklo (NYSE:OKLO) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $44.00 price target on the stock. This represents a 40.6% upside from the current price of $31.29. |
| Olin (NYSE:OLN) is now covered by analysts at Truist Financial Co.. They set a "hold" rating and a $38.00 price target on the stock. This represents a 13.4% upside from the current price of $33.50. |
| PolyPid (NASDAQ:PYPD) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock. This represents a 318.7% upside from the current price of $3.11. |
| Tanger (NYSE:SKT) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $36.00 price target on the stock. This represents a 7.3% upside from the current price of $33.57. |
| Talphera (NASDAQ:TLPH) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock. This represents a 446.4% upside from the current price of $0.73. |
| Tronox (NYSE:TROX) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $17.00 price target on the stock. This represents a 64.7% upside from the current price of $10.32. |
| Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $58.00 price target on the stock. This represents a 63.3% upside from the current price of $35.52. |
| Westlake (NYSE:WLK) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $168.00 price target on the stock. This represents a 40.4% upside from the current price of $119.65. |
Ratings changes for Advanced Micro Devices, Adobe, SoFi Technologies, Mind Medicine (MindMed), Celsius, Astera Labs, NetApp and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
